MFDS allows academic marketing of EUA COVID-19 treatments
By | translator Alice Kang
22.09.27 06:00:55
가나다라
0
Clarifies that the drugs “may be advertised like officially approved drugs”...to improve information access for HCPs
Gi-Seok Jeong, Director-General of Special Response of the Central Disaster and Safety Countermeasure Headquarters, “Pharmaceutical companies’ provision of information will help raise prescription rate”
The Ministry of Food and Drug Safety gave an interpretation that allows academic marketing activities for oral COVID-19 treatments. As drugs approved under the Emergency Use Authorization are as validly approved as officially authorized drugs, such drugs that were left unattended by the Pharmaceutical Affairs Act can also be advertised within its approved indication. With this favorable interpretation, the healthcare professionals’ access to information that arose as a barrier in prescribing COVID-19 treatments will also gain momentum and be improved.
During a phone interview with Dailypharm on the 26th, an official from the Ministry of Food and Drug Safety said, “The Korea Disease Control and
(same@dailypharm.com)
If you want to see the full article, please JOIN US (click)